These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 38583248)
1. Novel partially reversible NDM-1 inhibitors based on the naturally occurring houttuynin. Wang L; Liang Y; Luo P; Huang M; Wan Y Bioorg Chem; 2024 Jun; 147():107328. PubMed ID: 38583248 [TBL] [Abstract][Full Text] [Related]
2. Thiosemicarbazones exhibit inhibitory efficacy against New Delhi metallo-β-lactamase-1 (NDM-1). Ge Y; Kang PW; Li JQ; Gao H; Zhai L; Sun LY; Chen C; Yang KW J Antibiot (Tokyo); 2021 Sep; 74(9):574-579. PubMed ID: 34234284 [TBL] [Abstract][Full Text] [Related]
3. Dihydroxyphenyl-substituted thiosemicarbazone: A potent scaffold for the development of metallo-β-lactamases inhibitors and antimicrobial. Liu L; Xu YS; Chigan JZ; Zhai L; Ding HH; Wu XR; Chen WY; Yang KW Bioorg Chem; 2022 Oct; 127():105928. PubMed ID: 35717802 [TBL] [Abstract][Full Text] [Related]
4. H Chen F; Bai M; Liu W; Kong H; Zhang T; Yao H; Zhang E; Du J; Qin S Eur J Med Chem; 2021 Nov; 224():113702. PubMed ID: 34303873 [TBL] [Abstract][Full Text] [Related]
5. Bioisosteric investigation of ebselen: Synthesis and in vitro characterization of 1,2-benzisothiazol-3(2H)-one derivatives as potent New Delhi metallo-β-lactamase inhibitors. Jin WB; Xu C; Cheung Q; Gao W; Zeng P; Liu J; Chan EWC; Leung YC; Chan TH; Wong KY; Chen S; Chan KF Bioorg Chem; 2020 Jul; 100():103873. PubMed ID: 32361294 [TBL] [Abstract][Full Text] [Related]
6. The assemblage of covalent and metal binding dual functional scaffold for cross-class metallo-β-lactamases inhibition. Chen C; Liu Y; Zhang YJ; Ge Y; Lei JE; Yang KW Future Med Chem; 2019 Sep; 11(18):2381-2394. PubMed ID: 31544522 [No Abstract] [Full Text] [Related]
7. Ebsulfur as a potent scaffold for inhibition and labelling of New Delhi metallo-β-lactamase-1 in vitro and in vivo. Su J; Liu J; Chen C; Zhang Y; Yang K Bioorg Chem; 2019 Mar; 84():192-201. PubMed ID: 30502631 [TBL] [Abstract][Full Text] [Related]
8. NOTA analogue: A first dithiocarbamate inhibitor of metallo-β-lactamases. Zhang E; Wang MM; Huang SC; Xu SM; Cui DY; Bo YL; Bai PY; Hua YG; Xiao CL; Qin S Bioorg Med Chem Lett; 2018 Jan; 28(2):214-221. PubMed ID: 29248295 [TBL] [Abstract][Full Text] [Related]
9. Diaryl-substituted thiosemicarbazone: A potent scaffold for the development of New Delhi metallo-β-lactamase-1 inhibitors. Li JQ; Sun LY; Jiang Z; Chen C; Gao H; Chigan JZ; Ding HH; Yang KW Bioorg Chem; 2021 Feb; 107():104576. PubMed ID: 33383326 [TBL] [Abstract][Full Text] [Related]
10. N-acylhydrazones confer inhibitory efficacy against New Delhi metallo-β-lactamase-1. Gao H; Li JQ; Kang PW; Chigan JZ; Wang H; Liu L; Xu YS; Zhai L; Yang KW Bioorg Chem; 2021 Sep; 114():105138. PubMed ID: 34229201 [TBL] [Abstract][Full Text] [Related]
11. The activity and mechanism of vidofludimus as a potent enzyme inhibitor against NDM-1-positive E. coli. Li X; Zhao D; Zhao X; Cheng P; Li F; Sun J; Li Y; Bai J; Zhang X Eur J Med Chem; 2023 Mar; 250():115225. PubMed ID: 36870273 [TBL] [Abstract][Full Text] [Related]
12. Dipyridyl-substituted thiosemicarbazone as a potent broad-spectrum inhibitor of metallo-β-lactamases. Li JQ; Gao H; Zhai L; Sun LY; Chen C; Chigan JZ; Ding HH; Yang KW Bioorg Med Chem; 2021 May; 38():116128. PubMed ID: 33862468 [TBL] [Abstract][Full Text] [Related]
13. Targeting clinically-relevant metallo-β-lactamases: from high-throughput docking to broad-spectrum inhibitors. Brindisi M; Brogi S; Giovani S; Gemma S; Lamponi S; De Luca F; Novellino E; Campiani G; Docquier JD; Butini S J Enzyme Inhib Med Chem; 2016; 31(sup1):98-109. PubMed ID: 27121013 [TBL] [Abstract][Full Text] [Related]
14. Docking and antibacterial activity of novel nontoxic 5-arylidenepyrimidine-triones as inhibitors of NDM-1 and MetAP-1. Tumskiy RS; Tumskaia AV; Pylaev TE; Avdeeva ES; Evstigneeva SS Future Med Chem; 2021 Jun; 13(12):1041-1055. PubMed ID: 33913733 [No Abstract] [Full Text] [Related]
15. Mechanistic Investigations of Metallo-β-lactamase Inhibitors: Strong Zinc Binding Is Not Required for Potent Enzyme Inhibition*. Wade N; Tehrani KHME; Brüchle NC; van Haren MJ; Mashayekhi V; Martin NI ChemMedChem; 2021 May; 16(10):1651-1659. PubMed ID: 33534956 [TBL] [Abstract][Full Text] [Related]
16. Azolylthioacetamides as a potent scaffold for the development of metallo-β-lactamase inhibitors. Xiang Y; Chang YN; Ge Y; Kang JS; Zhang YL; Liu XL; Oelschlaeger P; Yang KW Bioorg Med Chem Lett; 2017 Dec; 27(23):5225-5229. PubMed ID: 29122480 [TBL] [Abstract][Full Text] [Related]
17. Benzimidazole and Benzoxazole Zinc Chelators as Inhibitors of Metallo-β-Lactamase NDM-1. Jackson AC; Pinter TBJ; Talley DC; Baker-Agha A; Patel D; Smith PJ; Franz KJ ChemMedChem; 2021 Feb; 16(4):654-661. PubMed ID: 33211374 [TBL] [Abstract][Full Text] [Related]
18. Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1. Chen AY; Thomas PW; Stewart AC; Bergstrom A; Cheng Z; Miller C; Bethel CR; Marshall SH; Credille CV; Riley CL; Page RC; Bonomo RA; Crowder MW; Tierney DL; Fast W; Cohen SM J Med Chem; 2017 Sep; 60(17):7267-7283. PubMed ID: 28809565 [TBL] [Abstract][Full Text] [Related]
19. Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli. Guo Y; Yang Y; Xu X; Li L; Zhou Y; Jia G; Wei L; Yu Q; Wang J Eur J Med Chem; 2022 Mar; 231():114108. PubMed ID: 35101651 [TBL] [Abstract][Full Text] [Related]
20. Efforts towards the inhibitor design for New Delhi metallo-beta-lactamase (NDM-1). Nagulapalli Venkata KC; Ellebrecht M; Tripathi SK Eur J Med Chem; 2021 Dec; 225():113747. PubMed ID: 34391033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]